What is the primary use of Methotrexate in relation to Crohn's disease?

Methotrexate is primarily used to provide remission maintenance in Crohn's disease. This medication is an immunosuppressant that helps decrease inflammation and manage the immune response, which is particularly beneficial in chronic inflammatory conditions like Crohn's disease. While it may not be the first choice for induction therapy, it plays a significant role in maintaining remission and preventing flare-ups once the disease is under control.

In the context of Crohn's disease, maintaining remission is crucial for improving patients' quality of life and preventing complications. Methotrexate can help achieve this by reducing the underlying inflammation associated with the disease. Therefore, its use in maintaining remission is a key aspect of managing Crohn's disease effectively.